| HOME >> BIOLOGY >> TECHNOLOGY |
Re: Animal Cloning and the Announcement of a Tracking Program for Cloned Livestock
WASHINGTON, Dec. 19 /PRNewswire-USNewswire/ -- The following is a statement by International Dairy Foods Association President and CEO Connie Tipton:
We view today's announcement of a new national registry to track cloned livestock as a needed first step in addressing consumer concerns over food products from cloned animals. However, we strongly urge the U.S. Food and Drug Administration (FDA) to continue the current voluntary moratorium on introducing milk and milk-derived products from cloned animals and their progeny. We further call on FDA to fully consider the unintended and negative economic and public health consequences in lifting the moratorium at this time.
IDFA supports congressional provisions adopted both in the 2008 omnibus spending bill and the Senate Farm Bill that would require additional studies before the FDA can issue a final Risk Assessment. Animal cloning is a relatively new niche market technology, and it's important that we have a thorough, deliberative dialogue where people can openly discuss any concerns they may have.
In a December 13, 2007, letter to the Biotechnology Industry Organization (BIO), IDFA, the National Milk Producers Federation (NMPF) and the U.S. Dairy Export Council (USDEC) called on BIO and its members to adopt a policy to continue the voluntary moratorium on introducing food products from cloned animals into the food supply until all major foreign markets have approved the same technology in their countries.
Contact: Jerry Slominski, IDFA Senior Vice President, 202-220-3512.
The International Dairy Foods Association (IDFA), Washington, D.C.,
represents the nation's dairy manufacturing and marketing industries and
their suppliers, with a membership of 530 companies representing a
$90-billion a year industry. IDFA is composed of three constituent
organizations: the Milk Industry Fou
'/>"/>
| SOURCE International Dairy Foods Association Copyright©2007 PR Newswire. All rights reserved |
Related biology technology :
1. VaxGen Files 2006 Financial Statements and Provides Cash Update
2. ARYx Therapeutics, Inc. Files Registration Statement for Initial Public Offering
3. Anacor Files Registration Statement for Initial Public Offering
4. IsoTis Files Definitive Proxy Statement
5. MAKO Surgical Corp. Files Registration Statement for Initial Public Offering of Common Stock
6. Statement on Direct-To-Consumer Genetic Testing
7. Coherent Announces Restatement Related to Stock-Based Compensation
8. XTL Biopharmaceuticals: AGM/EGM Statements
9. Statement from GPhA President and CEO Kathleen Jaeger on FDAs Generic Initiative
10. Symmetry Medical Discloses Accounting Issues at Sheffield, UK Operating Unit and Possible Restatement
11. CCPM Issues Statement on FDAs GIVE Initiative
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |